TABLE 3.
Strain | Species | Groupa | Resistance to OXAb | SCCmec type | Toxin type | PFGE pattern
|
|
---|---|---|---|---|---|---|---|
SmaI | AscI | ||||||
NVAU06003 | MRSA | Human | H | II | tst, sec, seg, sei | X1 | NDd |
NVAU06030 | MRSA | Dog-i | H | II | tst, sec, seg, sei | X2 | ND |
NVAU06032 | MRSA | Human | H | IV | None | Y | ND |
NVAU06013 | MRSP | Human | H | III | None | A4 | a1 |
NVAU06021 | MRSP | Dog-o | H | III | None | B2 | a4 |
NVAU06029 | MRSP | Dog-o | H | III | None | C2 | a1 |
NVAU06002 | MRSP | Dog-o | H | III | None | D | a1 |
NVAU06018 | MRSP | Dog-o | H | III | None | D | a1 |
NVAU06037 | MRSP | Dog-o | H | NTc | None | E | a3 |
NVAU06046 | MRSP | Dog-o | L | NT | None | H | a6 |
NVAU06016 | MRSP | Dog-i | H | III | None | A2 | a1 |
NVAU06017 | MRSP | Dog-i | H | III | None | A3 | a1 |
NVAU06022 | MRSP | Dog-i | H | III | None | B3 | a3 |
NVAU06031 | MRSP | Dog-i | H | III | None | C1 | a1 |
NVAU06039 | MRSP | Dog-i | H | III | None | C3 | a1 |
NVAU06045 | MRSP | Dog-i | L | V | None | F | a5 |
NVAU06043 | MRSP | Dog-i | H | NT | None | A1 | a1 |
NVAU06044 | MRSP | Dog-i | H | NT | None | A1 | a1 |
NVAU06034 | MRSP | Dog-I | H | NT | None | B1 | a1 |
NVAU06033 | MRSP | Dog-i | H | NT | None | B4 | a2 |
NVAU06038 | MRSP | Dog-i | L | NT | None | G | a6 |
Dog-o and Dog-i refer to outpatient and inpatient dogs, respectively.
H, high-level resistance to OXA (MIC of ≥128 μg/ml); L, low-level resistance to OXA (MIC of 0.5 to 64 μg/ml).
NT, nontypeable.
ND, not done.